Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)
China
· Delayed Price · Currency is CNY 26.25
+0.01 (0.04%)
At close: Apr 30, 2026
SHA:603207 Revenue
Shanghai Xiao Fang Pharmaceutical had revenue of 145.69M CNY in the quarter ending March 31, 2026, with 35.69% growth. This brings the company's revenue in the last twelve months to 504.59M, up 6.89% year-over-year. In the year 2024, Shanghai Xiao Fang Pharmaceutical had annual revenue of 474.58M with 0.57% growth.
Revenue (ttm)
504.59M
Revenue Growth
+6.89%
P/S Ratio
8.36
Revenue / Employee
1.25M
Employees
404
Market Cap
4.22B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| LanZhou Foci Pharmaceutical | 915.53M |
| Sinotherapeutics | 446.57M |
| Shandong Wohua Pharmaceutical | 818.16M |
| Shanghai Jiaoda Onlly Co.,Ltd | 314.12M |
| Zhuhai Rundu Pharmaceutical | 1.19B |
| Jinhe Biotechnology CO., LTD. | 2.88B |
| Newland Pharmaceutical | 659.54M |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.68B |